Skip to main content
. 2010 Jan 27;33(5):951–957. doi: 10.2337/dc09-1521

Figure 2.

Figure 2

Disposition index, M value, and M/I index before (□) and after (■) treatment with EXE, EXE+ROSI, and ROSI. *P < 0.05 when compared with baseline, †P < 0.05 between EXE+ROSI and ROSI at baseline. Data are LS means ± SE. BL, baseline; E, exenatide; E+R, exenatide plus rosiglitazone; EP, end point; I, steady-state plasma insulin concentration during the euglycemic clamp; M, insulin-stimulated glucose disposal during the euglycemic clamp; R, rosiglitazone.